1 / 24

Critical care conference

Critical care conference. Acute Kidney Injury: A Relevant Complication After Cardiac Surgery 2011 society of thoracic surgeons 主講人 : R2 顏介立. Introduction. Acute kidney injury (AKI) occurs in 40% patients

usoa
Download Presentation

Critical care conference

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Critical care conference Acute Kidney Injury: A Relevant Complication After Cardiac Surgery 2011 society of thoracic surgeons 主講人: R2 顏介立

  2. Introduction • Acute kidney injury (AKI) occurs in 40% patients after cardiac surgery, 1% requires dialysis - Poor outcome and high cost in AKI patient • AKI: consequence of interplay of different pathophysiologic mechanism • Several biomarkers for acute kidney injury • Protective therapy for AKI

  3. Acute kidney injury after cardiac surgery • Incidence of post-op AKI: 1%-30% of patient after cardiac surgery • Incidence of hemodialysis: 1%-6% of patient • Different type of cardiac operation: @ CABG: lowest incidence 2%-5% @ valvular disease or combied disease: 30% • Different AKI definition =>new classification critieria

  4. Classification of AKI criteria

  5. Pathology @ Post-op AKI: progressive course with different phase • Vasomotor change : alteration in vaso-reactivity and renal perfusion • Prerenal azotemia, ATP depletion, oxidative injury => bone marrow/ endothelium: proinflammatory state • Inflammatory cells adhere peritubular capillaries=> proximal tubule • Proliferation of tubule cells=> function reconstitution  post-operative AKI is acute tubular necrosis

  6. Pathogenesis • AKI is the consequence of different mechanisms inerplay • Major cause: • 1. CPB (cardiopulmonary bypass) 2. patient-related factor( risk factor)

  7. Pathogenesis • Cardiopulmonary bypass (CPB) • Kidney blood circulation • ischemia-reperfusion injury, low cardiac ouput hemodilution, loss of pulsatile flow • Hypothermia • CPB induced systemic inflammation • CPB related emoblization

  8. Risk Factor -many factor associated with AKI • pre-op renal function: baseline creatinine 2-4 =>10-20% hemodialysis baseline creatinine > 4 =>30% hemodialysis • pre-op anemia • DM • Intravenous contrast and ACEi Identified risk factor associated with AKI is important

  9. Pathogenesis

  10. Biomarkers for AKI • Problem of conventional renal biomarker 1. become abnormal too late (urea, creatinine) 2. lack specificity (urine ouput) • New biomarker of AKI ex. cystatin C, NGAL(neutrophil gelatinase associated lipocalin), IL-6, IL-18, KIM-1( kidney injury molecule-1) , L-FABP, NAG…….

  11. Biomarkers for AKI • Neutrophil gelatinase-associated lipocalin(NGAL) @Measure tubular stress, increase after tubular injury @precedes creatinine more than 24hrs!! • Liver type FABP @ cell uptake fatty acid and promote metabolism @ increase within 4hr after surgery, accuracy of 81% of AKI development - KIM-1(kidney injury molecular-1) @ predict AKI immediately after surgery=>than NGAL @ more specific to ischemic injury than NGAL

  12. Strategies to prevent AKI • Difficulty of AKI prevention: complex AKI pathophysiology • Intravenous contrast - vasoconstriction-mediated medullary ischemia and direct cytotoxicity on glomerular cells - delay cardiac surgery beyond 24hrs of exposure to contrast

  13. Strategies to prevent AKI 2. Drugs increasing blood flow a. dopamine: no protective effect and even exacerbate renal tubular injury b. Fenoldopam: increase renal blood flow in dose-dependent manner

  14. Strategies to prevent AKI c. Atrial and brain natriuretic peptide increase GFR and inhibit sodium reabsorption => decrease renal dysfunction d. Agent attenuating systemic inflammaatory -Statins attenuate inflammation and oxidative stress - N-acetylcysteine, dexamethasone,….. etc. (anti-inflammation agent)

  15. Strategies to prevent AKI

  16. Strategies to prevent AKI e. CPB use • The most relevant pathophysiologic mechanism • nonpulsatile flow @ pulsatile perfusion =>improved renal protection -Presta and colleagues research (2009) • Poor oxygen availability to renal medulla when CPB @ Hct<26% , oxygen delivery less than 272ml/kg/min (Ranucci and collegue, 2005) @pump flow > 3.0L /min/m2(von Heymann, 2006)

  17. Strategies to prevent AKI e. CPB use • off-pump coronary bypass graft technique @ controversial renal effect

  18. Cost and Outcomes • post-op AKI has shown to be related to poor prognosis • Relationship between In-hospital mortality and post-op GFR (Thakear and colleagues, 2005) • Less than 30% decline GFR • Mortality 0.4% • More than 30% decline • Mortality 5.9% • Hemodialysis => Mortality 54%

  19. Cost and Outcomes - AKI contributes to long- term mortality @10years survival rate with RIFLE criteria (Hobson and colleague 2009) Risk: 51% Injury: 42% failure: 26%

  20. Cost and Outcomes • Duration of AKI with long-term survival @long term mortality is proportional to AKI duration @importance of continuous monitoring of renal function

  21. Cost and Outcomes post-op AKI mortality • Plausible mechanism : . Fluid overloading, dialysis catheter insertion, impaired host immunity and infection @ post-op infection: (Thaker and colleague 2003) 1.6% without AKI, 23.7% with AKI, 58.5 % with hemodialysis

  22. Cost and Outcomes • Hospital cost and length of stay increase as AKI severity worsen @ post- op AKI: higher intensive care unit cost(1.7-fold) pharmacy cost(2.3-fold) laboratory cost (1.6-fold)

  23. Conclusion • Acute kidney injury after cardiac surgery -increase mortality and morbidity. Longer hospitalization and increase cost -consequence of interplay of different mechanism - patients who are at high risk - novel renal biomarker - protective strategies

  24. Thank you for your attention !! Any question????

More Related